| abstract |
The present invention provides compounds which are modulators of RORĪ³ and their use for the treatment of diseases or conditions mediated by RORĪ³. Further, the present invention relates to processes of preparing such compounds, their tautomeric forms, novel intermediates involved in their synthesis, their pharmaceutically acceptable salts, methods for using such compounds and pharmaceutical compositions containing them (Formula I). |